PNC Financial Services Group
MRTX

PNC Financial Services Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

PNC Financial Services Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-242
Closed -$14.2K – 4865
2023
Q4 		$14.2K Buy
242
+3
+1% +$169 ﹤0.01% 3598
2023
Q3 		$10.4K Buy
239
+103
+76% +$3.68K ﹤0.01% 3746
2023
Q2 		$4.91K Buy
136
+18
+15% +$742 ﹤0.01% 4116
2023
Q1 		$4.39K Sell
118
-9
-7% -$405 ﹤0.01% 4082
2022
Q4 		$5.75K Sell
127
-240
-65% -$15.5K ﹤0.01% 3961
2022
Q3 		$25K Buy
367
+211
+135% +$15.6K ﹤0.01% 3358
2022
Q2 		$11K Sell
156
-89
-36% -$5.66K ﹤0.01% 3784
2022
Q1 		$20K Buy
245
+192
+362% +$19.6K ﹤0.01% 3588
2021
Q4 		$7K Sell
53
-25
-32% -$3.88K ﹤0.01% 3902
2021
Q3 		$15K Buy
78
+27
+53% +$4.34K ﹤0.01% 3631
2021
Q2 		$7K Buy
51
+21
+70% +$3.37K ﹤0.01% 3809
2021
Q1 		$4K Buy
30
+14
+88% +$2.77K ﹤0.01% 3880
2020
Q4 		$4K Buy
+16
New +$3.46K ﹤0.01% 3775
2020
Q3 		– Sell
-517
Closed -$59K – 4086
2020
Q2 		$59K Sell
517
-19,140
-97% -$1.86M ﹤0.01% 2674
2020
Q1 		$1.51M Buy
19,657
+4,694
+31% +$421K ﹤0.01% 813
2019
Q4 		$1.93M Buy
14,963
+3,713
+33% +$358K ﹤0.01% 823
2019
Q3 		$877K Sell
11,250
-85
-0.7% -$7.98K ﹤0.01% 1314
2019
Q2 		$1.17M Buy
+11,335
New +$882K ﹤0.01% 1219
2018
Q4 		– Sell
-7,820
Closed -$369K – 4212
2018
Q3 		$369K Sell
7,820
-5,290
-40% -$294K ﹤0.01% 1846
2018
Q2 		$647K Buy
13,110
+13,018
+14,150% +$492K ﹤0.01% 1504
2018
Q1 		$3K Hold
92
– – ﹤0.01% 4000
2017
Q4 		$2K Hold
92
– – ﹤0.01% 4031
2017
Q3 		$1K Buy
+92
New +$532 ﹤0.01% 4097

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PNC Financial Services Group's MRTX Position: Q1 2024 in Review

PNC Financial Services Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 242 shares — an estimated $14.2K sold.

PNC Financial Services Group first reported a position in MRTX in Q3 2017 and held it in 23 quarters. The position peaked at $1.93M in Q4 2019. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • PNC Financial Services Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 242 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $14.2K.
  • PNC Financial Services Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2017 and held it in 23 quarters.
  • PNC Financial Services Group's Mirati Therapeutics, Inc. Common Stock position peaked at $1.93M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.